Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations

American Journal of Gastroenterology

Volumn 100, Issue 5, 2005, Pages 1167-1173

  Mahnel, René ^a   Kalt, Anja ^c   Ring, Sabine ^a   Stallmach, Andreas ^c   Strober, Warren ^b   Marth, Thomas ^d  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c SAARLAND UNIVERSITY   (Germany)

^d St Josef Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; DICLOFENAC; GOLD; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PHENYLBUTAZONE; ANTIINFECTIVE AGENT; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INTESTINE LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; POLYARTHRITIS; PRIORITY JOURNAL; RARE DISEASE; RHEUMATOID ARTHRITIS; SERODIAGNOSIS; SYMPTOMATOLOGY; SYSTEMIC DISEASE; TROPHERYMA WHIPPELII; ARTHRITIS; BIOPSY; CENTRAL NERVOUS SYSTEM DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; FOLLOW UP; IMMUNOLOGY; MIDDLE AGED; ONSET AGE; PATHOPHYSIOLOGY; RECURRENT DISEASE; TIME; WEIGHT REDUCTION;

AGE OF ONSET; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS; BIOPSY; CENTRAL NERVOUS SYSTEM DISEASES; COHORT STUDIES; DIARRHEA; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS; WEIGHT LOSS; WHIPPLE DISEASE;

EID: 19144364222     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.40128.x     Document Type: Article

References (36)

1. Relman DA, Schmidt TM, MacDermott RP, et al. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992;327:293-301.
2. Raoult D, Birg ML, La Scola B, et al. Cultivation of the bacillus of Whipple's disease. N Engl J Med 2000;342:620-5.
3. Marth T. The diagnosis and treatment of Whipple's disease. Curr Allergy Asthma Rep 2001;1:566-71.
4. Marth T, Raoult D. Whipple's disease. Lancet 2003;361: 239-46.
5. Dobbins WO. Whipple's disease. Springneld(IL): CC Thomas, 1987.
6. Wilson KH, Blitchington R, Frothingham R, et al. Phylogeny of the Whipple's-disease-associated bacterium. Lancet 1991;338:474-5.
7. Hamrock D, Azmi FH, O'Donnell E, et al. Infection by Rhodococcus equi in a patient with AIDS: Histological appearance mimicking Whipple's disease and Mycobacterium avium-intracellulare infection. J Clin Pathol 1999;52:68-71.
8. Bentley SD, Maiwald M, Murphy LD, et al. Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei. Lancet 2003;361:1916.
9. Schoedon G, Goldenberger D, Forrer R, et al. Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whipplei. J Infect Dis 1997;176:672-7.
10. Gisbertz IA, Bergmans DC, van Marion-Kievit JA, et al. Concurrent Whipple's disease and Giardia lamblia infection in a patient presenting with weight loss. Eur J Intern Med 2001;12:525-8.
11. Maxwell JD, Ferguson A, McKay AM, et al. Lymphocytes in Whipple's disease. Lancet 1968;1:887-9.
12. Groll A, Valberg LS, Simon JB, et al. Immunological defect in Whipple's disease. Gastroenterology 1972;63:943-50.
13. Meier-Willersen HJ, Maiwald M, von Herbay A. Whipple's disease associated with opportunistic infections. Dtsch Med Wochenschr 1993;118:854-60.
14. Feurle GE, Dörken B, Schopf E, et al. HLA B27 and defects in the T-cell system in Whipple's disease. Eur J Clin Invest 1979;9:385-9.
15. Olivieri I, Brandi G, Padula A, et al. Lack of association with spondyloarthritis and HLA-B27 in Italian patients with Whipple's disease. J Rheumatol 2001;28:1294-7.
16. Bai JC, Mota AH, Maurino E, et al. Class I and class II HLA antigens in a homogeneous Argentinian population with Whipple's disease: Lack of association with HLA-B 27. Am J Gastroenterol 1991;86:992-4.
17. Gruner U, Goesch P, Donner A, et al. Whipple disease and non-Hodgkin lymphoma. Z Gastroenterol 2001;39:305-9.
18. Paulley JW. A case of Whipple's disease (intestinal lipodystrophy). Gastroenterology 1952;22:128-33.
19. Ectors N, Geboes K, De Vos R, et al. Whipple's disease: A histological, immunocytochemical and electronmicroscopic study of the immune response in the small intestinal mucosa. Histopathology 1992;21:1-12.
20. Marth T, Roux M, von Herbay A, et al. Persistent reduction of complement receptor 3 alpha-chain expressing mononuclear blood cells and transient inhibitory serum factors in Whipple's disease. Clin Immunol Immunopathol 1994;72:217-26.
21. Lukacs G, Dobi S, Szabo M. A case of whipple's disease with repeated operations for ileus and complete cure. Acta Hepatogastroenterol (Stuttg) 1978;25:238-42.
22. Marth T, Kleen N, Stallmach A, et al. Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease. Gastroenterology 2002;123:1468-77.
23. Marth T, Neurath M, Cuccherini BA, et al. Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease. Gastroenterology 1997;113:442-8.
24. Feurle GE, Marth T. An evaluation of antimicrobial treatment for Whipple's Disease. Tetracycline versus trimethoprim-sulfamethoxazole. Dig Dis Sci 1994;39: 1642-8.
25. Bittner K, Tegtmeier L, Heymanns J, et al. Arterial thromboses as a complication of Whipple disease. Med Klin (Klin) 1987;82:421-4.
26. Hinrikson HP, Dutly F, Nair S, et al. Detection of three different types of "Tropheryma whipplei" directly from clinical specimens by sequencing, single-strand conformation polymorphism (SSCP) analysis and type-specific PCR of their 16S-23S ribosomal intergenic spacer region. Int J Syst Bacteriol 1999;49:1701-6.
27. Rosenblatt H. Immunodeficiencies associated with medical therapy. In: Rich RR, Fleisher TA, Schwartz BD, eds. Clinical immunology: Principles and practice. St. Louis(MO): CV Mosby, 1995:824-35.
28. Berg RD, Wommack E, Deitch EA. Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation. Arch Surg 1988;123:1359-64.
29. Renesto P, Crapoulet N, Ogata H, et al. Genome-based design of a cell-free culture medium for Tropheryma whipplei. Lancet 2003;9(362):447-9.
30. Gross JB, Wollaeger Sauer WG, et al. Whipple's disease: report of four cases, including two brothers, with observations on pathologic physiology, diagnosis, and treatment. Gastroenterology 1959;36:65.
31. Ambler MW, Homans AC, O'Shea PA. An unusual central nervous system infection in a young immunocompromised host. Arch Pathol Lab Med 1986;110:497-501.
32. Maiwald M, Meier-Willersen HJ, Hartmann M, et al. Detection of Tropheryma whipplei DNA in a patient with AIDS. J Clin Microbiol 1995;33:1354-6.
33. Autran B, Gorin I, Leibowitch M, et al. AIDS in a Haitian woman with cardiac Kaposi's sarcoma and Whipple's disease. Lancet 1983;1:767-8.
34. Jankovic J. Whipple's disease of the central nervous system in AIDS. N Engl J Med 1986;16(315):1029-30.
35. Fennolar F, Lepidi II, Gerolami R, et al. Whipple disease associated with giardiasis. J Infect Dis 2003;188:828-34.
36. Fest T, Pron B, Lefranc MP, et al. Detection of a clonal BCL2 gene rearrangement in tissues from a patient with Whipple disease. Arm Intern Med 1996;124:738-40.